SCHEMBL2026047

SCHEMBL2026047

O=c1cnc2ncncc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.40
METAP1 P53582 1/20 0.40
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPKAPK2 P49137 1/20 0.38
RPS6KA3 P51812 1/20 0.38
CSNK2A1 P68400 1/20 0.38
PLK3 Q9H4B4 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
KDM5A P29375 1/20 0.33
NPY5R Q15761 1/20 0.32
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL277595 0.71 METAP2 (0.47) METAP2METAP1NPY5R
Purine SCHEMBL763130 0.70 LMNA (0.35) ALDH1A1KDM4ELMNA
SCHEMBL19094567 0.69 NOS3 (0.40) ALDH1A1KDM4EHSD17B10MAPKAPK2RPS6KA3
SCHEMBL329703 0.69 METAP2 (0.43) METAP2METAP1NPY5R
SCHEMBL927587 0.69 NUDT1 (0.48) METAP2METAP1KDM4EMAPKAPK2RPS6KA3
SCHEMBL4146190 0.69 SMN1; SMN2 (0.55) ALDH1A1KDM4EHSD17B10MAPKAPK2RPS6KA3
SCHEMBL30891689 0.69 PDE3B (0.44) ALDH1A1MAPKAPK2RPS6KA3CSNK2A1PLK3
SCHEMBL4297906 0.69 AURKA (0.43) ALDH1A1KDM4EHSD17B10MAPKAPK2RPS6KA3
SCHEMBL3020577 0.69 MAPKAPK2 (0.41) ALDH1A1KDM4EHSD17B10MAPKAPK2RPS6KA3
SCHEMBL8354989 0.68 METAP2 (0.42) METAP2METAP1NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5854419-A Tricyclic pteridinones and a process for their preparation SCHERING AKTIENGESELLSCHAFT (DE) 1998-12-29 US claimed
CN-120020133-A Nitrogen-containing heterocyclic derivative and medical application thereof 杭州百新生物医药科技有限公司 2025-05-20 CN disclosed
WO-2025096494-A1 UBIQUITIN SPECIFIC PROCESSING PROTEASE 1 (USP1) COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-05-08 WO disclosed
CN-119930632-A Tri-ring ubiquitin-specific protease 1 inhibitor, and preparation method, application and pharmaceutical composition thereof 中国医学科学院药物研究所 2025-05-06 CN disclosed
CN-119930633-A Pyrrolopyrrolidone ubiquitin specific protease 1 inhibitor, and preparation method, application and pharmaceutical composition thereof 中国医学科学院药物研究所 2025-05-06 CN disclosed
CN-115813928-B Arginine methyltransferase PRMT1 inhibitor and application thereof 厦门大学 2025-03-11 CN disclosed
CN-117402160-A Wnt pathway inhibitor compound 杭州阿诺生物医药科技有限公司 2024-01-16 CN disclosed
CN-115043840-A Methods for preparing TOLL-like receptor modulators 吉利德科学公司 2022-09-13 CN disclosed
CN-107074860-B Methods for preparing TOLL-like receptor modulators 吉利德科学公司 2022-07-15 CN disclosed
EP-2920178-A1 NOVEL HETEROCYCLIC DERIVATIVES AS MODULATORS OF KINASE ACTIVITY Merck Patent GmbH (DE) 2015-09-23 EP disclosed
CN-101686981-A Diazo bicyclic SMAC mimetics and uses thereof UNIV MICHIGAN 2010-03-31 CN disclosed
CN-101171241-A Chromen-4-one inhibitors of anti-apoptotic BCL-2 family members and the uses thereof UNIV MICHIGAN (US) 2008-04-30 CN disclosed
CN-101132783-A Apogossypolone and the uses thereof UNIV MICHIGAN (US) 2008-02-27 CN disclosed
CN-1960719-A Gossypol co-crystals and the use thereof UNIV MICHIGAN (US) 2007-05-09 CN disclosed
CN-1960728-A Conformationally constrained SMAC mimetics and uses thereof UNIV MICHIGAN (US) 2007-05-09 CN disclosed
CN-1933847-A SMAC peptidomimetics and the uses thereof UNIV MICHIGAN (US) 2007-03-21 CN disclosed
EP-1066286-A4 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2004-02-11 EP disclosed
EP-1066286-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-01-10 EP disclosed
WO-1999045009-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-09-10 WO disclosed
US-5854419-A Tricyclic pteridinones and a process for their preparation SCHERING AKTIENGESELLSCHAFT (DE) 1998-12-29 US disclosed